Editorial & Opinion
أعرض في EDS

Combined central and peripheral demyelination after COVID-19 vaccination.

التفاصيل البيبلوغرافية
العنوان: Combined central and peripheral demyelination after COVID-19 vaccination.
المؤلفون: Coelho P; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal. peminco@gmail.com., Paula A; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal., Martins IV; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal., de Campos CF; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal.; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Ferreira J; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal.; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Antunes AP; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal.; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal., Albuquerque L; Serviço de Neurologia, Departamento de Neurociências e Saúde Mental, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Avenida Professor Egas Moniz, 1649-035, Lisbon, Portugal.; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
المصدر: Journal of neurology [J Neurol] 2022 Sep; Vol. 269 (9), pp. 4618-4622. Date of Electronic Publication: 2022 May 18.
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin ; New York, Springer-Verlag
مواضيع طبية MeSH: COVID-19*/prevention & control , Demyelinating Diseases*/diagnostic imaging , Demyelinating Diseases*/etiology, COVID-19 Vaccines/adverse effects ; Humans ; Vaccination/adverse effects
References: Cortese A, Franciotta D, Alfonsi E et al (2016) Combined central and peripheral demyelination: clinical features, diagnostic findings, and treatment. J Neurol Sci 363:182–187. https://doi.org/10.1016/j.jns.2016.02.022. (PMID: 10.1016/j.jns.2016.02.02227000248)
Ogata H, Matsuse D, Yamasaki R et al (2015) A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2014-309831. (PMID: 10.1136/jnnp-2014-30983125673872)
Kawamura N, Yamasaki R, Yonekawa T et al (2013) Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 81(8):714–722. https://doi.org/10.1212/WNL.0b013e3182a1aa9c. (PMID: 10.1212/WNL.0b013e3182a1aa9c23884033)
AlKolfat F, Elfatatry A, Mekky J, Aly AS (2022) Combined peripheral and central nervous system demyelination post-COVID-19 vaccination: a case report. Neuroimmunol Rep 2:100057. https://doi.org/10.1016/j.nerep.2022.100057. (PMID: 10.1016/j.nerep.2022.100057)
Matteo E, Romoli M, Calabrò C et al (2021) Combined central and peripheral demyelination with anti-neurofascin155 IgG following COVID-19 vaccination. Can J Neurol Sci. https://doi.org/10.1017/cjn.2021.256. (PMID: 10.1017/cjn.2021.256351070628814467)
Zephir H, Stojkovic T, Latour P et al (2008) Relapsing demyelinating disease affecting both the central and peripheral nervous systems. J Neurol Neurosurg Psychiatry 79(9):1032–1039. https://doi.org/10.1136/jnnp.2006.108290. (PMID: 10.1136/jnnp.2006.10829018208860)
Kira J (2021) Anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy/combined central and peripheral demyelination: strategies for diagnosis and treatment based on the disease mechanism. Front Neurol 12:665136. https://doi.org/10.3389/fneur.2021.665136. (PMID: 10.3389/fneur.2021.665136341777708222570)
Lambrianides S, Kinnis E, Cleanthous M, Myrianthopoulou P, Leonidou E, Kyriakides T (2021) A case of combined central and peripheral demyelination associated with antineurofascin 155 antibodies and paternal history of multiple sclerosis. Neurologist 26(4):156–159. https://doi.org/10.1097/NRL.0000000000000313. (PMID: 10.1097/NRL.000000000000031334190211)
Garcia J, Tchikviladze M, Evrard S et al (2017) Paranodopathie à anticorps anti-neurofascine 155: atteinte conjointe du système nerveux central et périphérique. À propos d’un cas et revue de la littérature. Pratique Neurologique - FMC. 8(3):156–160. https://doi.org/10.1016/j.praneu.2017.06.001. (PMID: 10.1016/j.praneu.2017.06.001)
Sokmen O, Demirci M, Tan E (2021) A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: successfully treated with anti-CD20 monoclonal antibody. Clin Neurol Neurosurg 210:106961. https://doi.org/10.1016/j.clineuro.2021.106961. (PMID: 10.1016/j.clineuro.2021.10696134624826)
Vural A, Göçmen R, Kurne AT et al (2016) Fulminant central plus peripheral nervous system demyelination without antibodies to neurofascin. Can J Neurol Sci 43(1):149–156. https://doi.org/10.1017/cjn.2015.238. (PMID: 10.1017/cjn.2015.23826271726)
Falcone M, Scalise A, Minisci C, Romito D, Cancelli I, Gigli GL (2006) Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Neurol Sci 27(1):58–62. https://doi.org/10.1007/s10072-006-0565-3. (PMID: 10.1007/s10072-006-0565-316688601)
Rinaldi S, Davies A, Fehmi J et al (2021) Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders. Neurol Neuroimmunol Neuroinflamm 8(1):e924. https://doi.org/10.1212/NXI.0000000000000924. (PMID: 10.1212/NXI.000000000000092433272955)
Vazquez Do Campo R, Stephens A, Marin Collazo IV, Rubin DI (2018) MOG antibodies in combined central and peripheral demyelination syndromes. Neurol Neuroimmunol Neuroinflamm. 5(6):e503. https://doi.org/10.1212/NXI.0000000000000503. (PMID: 10.1212/NXI.0000000000000503302460576147156)
Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E (2021) Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Revue Neurologique 177(1–2):51–64. https://doi.org/10.1016/j.neurol.2020.10.001. (PMID: 10.1016/j.neurol.2020.10.00133446327)
Dias da Costa M, Leal Rato M, Cruz D, Valadas A, Antunes AP, Albuquerque L (2021) Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection. J Neuroimmunol 361:577739. https://doi.org/10.1016/j.jneuroim.2021.577739. (PMID: 10.1016/j.jneuroim.2021.577739346281348492014)
Allen CM, Ramsamy S, Tarr AW et al (2021) Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol 90(2):315–318. https://doi.org/10.1002/ana.26144. (PMID: 10.1002/ana.2614434114269)
Haber P, Sejvar J, Mikaeloff Y, DeStefano F (2009) Vaccines and Guillain-Barre Syndrome. Drug Saf 15:309–323. (PMID: 10.2165/00002018-200932040-00005)
Karussis D, Petrou P (2014) The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 13(3):215–224. https://doi.org/10.1016/j.autrev.2013.10.003. (PMID: 10.1016/j.autrev.2013.10.00324514081)
Ismail II, Salama S (2022) A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol 362:577765. https://doi.org/10.1016/j.jneuroim.2021.577765. (PMID: 10.1016/j.jneuroim.2021.57776534839149)
Oo WM, Giri P, de Souza A (2021) AstraZeneca COVID-19 vaccine and Guillain-Barré Syndrome in Tasmania: a causal link? J Neuroimmunol 360:577719. https://doi.org/10.1016/j.jneuroim.2021.577719. (PMID: 10.1016/j.jneuroim.2021.577719345603658447540)
Lee WS, Wheatley AK, Kent SJ, DeKosky BJ (2020) Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol 5(10):1185–1191. https://doi.org/10.1038/s41564-020-00789-5. (PMID: 10.1038/s41564-020-00789-532908214)
المشرفين على المادة: 0 (COVID-19 Vaccines)
تواريخ الأحداث: Date Created: 20220518 Date Completed: 20220811 Latest Revision: 20220824
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9116708
DOI: 10.1007/s00415-022-11188-7
PMID: 35585333
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-1459
DOI:10.1007/s00415-022-11188-7